Related Experiment Video
Updated: May 24, 2025

05:19
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
2.1K
Enhancing Emotional Well-Being With IoT Data Solutions for Depression: A Systematic Review
IEEE Journal of Biomedical and Health Informatics
|March 3, 2025
Summary
Internet of Things (IoT) can improve depression management through data collection and analysis. However, a gap exists in user-engaging systems, emphasizing the need for better privacy and security in developing these technologies.
Area of Science:
- Digital Health
- Mental Health Technology
- Systematic Literature Review
Background:
- Managing adult depression presents significant challenges.
- Technology offers potential for enhanced emotional well-being monitoring.
- Current data collection and analysis methods for depression are fragmented.
Purpose of the Study:
- To explore the use of Internet of Things (IoT) for data collection and analysis in managing depression.
- To identify how IoT can enhance emotional well-being and depression management.
- To review existing literature on IoT applications in mental health.
Main Methods:
- Systematic Literature Review (SLR) following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework.
- Selection of 42 studies from an initial pool of 559 published works.
- Analysis of literature on IoT for emotion detection, analysis, monitoring, and depression management.
Main Results:
- Extensive coverage found in literature regarding IoT for emotion detection, analysis, and monitoring.
- Significant focus on therapeutic interventions for emotional well-being and depression management.
- Predominant use of sensors for IoT data collection and Artificial Intelligence (AI) for analysis.
Conclusions:
- A notable gap exists in prioritizing active, user-engaging IoT systems for depression management.
- There is a critical need to address privacy and security concerns in IoT-based mental health solutions.
- Further research should focus on developing integrated and secure IoT platforms for effective depression care.
More Related Videos
Related Concept Videos
Depression: Overview
206
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
206
Interpersonal Psychotherapy
19
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
19
Depressive Disorders: Etiology
27
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
27
Antidepressant Drugs: MAOIs and Other Agents
175
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
175

